Review: Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease

This publication has 76 references indexed in Scilit:

• Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
  The American Journal of Cardiology, 1996
• Apo(a) Phenotypes and Lp(a) Concentrations in Offspring of Men With and Without Myocardial Infarction
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Evidence that apolipoprotein(a) phenoptype is a risk factor for coronary artery disease in men < 55 years of age
  The American Journal of Cardiology, 1994
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)
  European Journal of Clinical Investigation, 1994
• Apolipoproteins and ischaemic heart disease: implications for screening
  The Lancet, 1994
• Effects of One Year of Treatment with Pravastatin, an HMG‐CoA Reductase Inhibitor, on Lipoprotein a
  The Journal of Clinical Pharmacology, 1993
• Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
  The American Journal of Cardiology, 1992
• Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1990
• Lipoprotein Lp(a). A risk factor for myocardial infarction.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor
  Clinical Genetics, 1981